bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
9.39
-1.11 (-10.57%)
At close: Sep 10, 2026, 4:00 PM EDT
9.49
+0.10 (1.06%)
After-hours: Sep 10, 2026, 6:52 PM EDT
bioAffinity Technologies Revenue
bioAffinity Technologies had revenue of $1.51M in the quarter ending June 30, 2026, with 18.99% growth. This brings the company's revenue in the last twelve months to $5.90M, down -23.17% year-over-year. In the year 2025, bioAffinity Technologies had annual revenue of $6.16M, down -34.18%.
Revenue (ttm)
$5.90M
Revenue Growth
-23.17%
P/S Ratio
0.86
Revenue / Employee
$103,526
Employees
57
Market Cap
5.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.16M | -3.20M | -34.18% |
| Dec 31, 2024 | 9.36M | 6.83M | 269.68% |
| Dec 31, 2023 | 2.53M | 2.53M | 52,627.44% |
| Dec 31, 2022 | 4.80K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| MDxHealth | 114.02M |
| Biodesix | 102.94M |
| Burning Rock Biotech | 74.58M |
| Exagen | 71.12M |
| XWELL | 28.28M |
| Precipio | 27.20M |
| Insight Molecular Diagnostics | 1.67M |
| Quantum Cyber | 537.08K |
BIAF News
- 1 day ago - BioAffinity Technologies regains compliance with Nasdaq listing requirements - TheFly
- 1 day ago - bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements - Business Wire
- 6 days ago - bioAffinity Technologies Inc trading resumes - TheFly
- 6 days ago - bioAffinity Technologies Inc trading halted, volatility trading pause - TheFly
- 7 days ago - bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 7 days ago - bioAffinity Technologies Registration statement: Registration filing - Filings
- 9 days ago - Why Is Penny Stock BioAffinity Technologies (BIAF) Up Today? - TipRanks
- 9 days ago - BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance - TheFly